期刊文献+

石胆酸腺苷的合成研究 被引量:1

Synthesis of Lithocholic Acid Adenosine
下载PDF
导出
摘要 腺苷衍生物是由天然腺苷经过化学方法对糖基取代或修饰的一类化合物,具有抗癌、抗病毒、抗肿瘤,镇静、催眠等生理活性。甾体化合物石胆酸是一种次级胆汁酸,具有抑制肿瘤生长,杀死癌细胞等生理活性。本文以腺苷为起始原料,经氯硅烷保护羟基,选择性脱保护,酰基化,石胆酸酰胺化,脱硅基保护基五步合成石胆酸腺苷,总收率为9%。 Adenosine derivatives are natural adenosine chemically modified glycosyl group of compounds,with anti-cancer,anti-virus,anti-tumor,sedative,hypnotic and other physiological activities. Steroid Lithocholic acid is a secondary bile acid,with inhibition of tumor growth,killing cancer cells and other physiological activities. In this paper,Lithocholic acid adenosine was synthesized starting from adenosine via chlorosilane protection,selective deprotection,acylation,lithocholic acid amidation and deprotection with the total yield 9%.
出处 《山东化工》 CAS 2018年第4期1-2,6,共3页 Shandong Chemical Industry
基金 国家自然科学基金项目(No.21602083)
关键词 石胆酸 腺苷 衍生物 合成 lithocholic acid adenosine derivative synthesis
  • 相关文献

参考文献4

二级参考文献45

  • 1WOLTERS L M, NIESTERS H G, de MAN R A, et al.Nucleoside analogues for chronic hepatitis B [J]. Eur J Gast roenterol Hepatol,2001,13( 12):1499-1506.
  • 2BENHAMOUY,BOCHET M,THIBAULT V, et al. Safety and efficacy of adefovirdipivoxil in patients co-infected with HIV-1 and lamivudine-resistant hepatitis B virus:an open-label pilot study [J]. Lancet,2001,358(9283):718-723.
  • 3Margolis H S. Hepatitis B virus infection[J]. Bull World Health Organ, 1998, 76 (Suppl.2):152-153.
  • 4Wen Y M, Lin X, Ma Z M. Exploiting new potential targets for anti-hepatitis B virus drugs[J]. Curr Drug Targets Infect Disord, 2003, 3(3):241-246.
  • 5Marchbanks C R, Mikolich D J, Mayer K H, et al. Pharmacokinetics and bioavailability of intravenous-to-oral enoxacin in elderly patients with complicated urinary tract infections[J]. Antimicrob Agents Chemother, 1990, 34(10):1966-1972.
  • 6Lin T S, Luo M Z, Liu M C, et al. Design and synthesis of 2′,3′-dideoxy-2′,3′-didehydro-β-Lcytidine (L-d4C) and 2′,3′-dideoxy-2′,3′-didehydro-β-L-5- fluorocytidine (β-L-Fd4C), two exceptionally potent inhibitors of human hepatitis B virus (HBV) and potent inhibitors of human immunodeficiency virus (HIV) in vitro[J]. J Med Chem, 1996,39(9):1757-1759.
  • 7Furman P A, Jeffrey J, Kiefer L L, et al. Mechanism of action of 1-beta-D-2,6-diaminopurine dioxolane, a prodrug of the human immunodeficiency virus type 1 inhibitor 1-beta-D-dioxolane guanosine[J]. Antimicrob Agents Chemother, 2001, 45(1):158-165.
  • 8Chu C K, Ma L, Olgen S, et al. Synthesis and antiviral activity of oxaselenolane nucleosides[J]. J Med Chem, 2000, 43(21):3906-3912.
  • 9Honkoop P, De Man R A. Entecavir: a potent new antiviral drug for hepatitis B[J]. Expert Opin Investig Drugs, 2003, 12(4):683-688.
  • 10Tenney D J, Levine S M, Rose R E, et al. Clinical emergence of entecavir-resistant hepatitis B virus requires additional substitutions in virus already resistant to Lamivudine[J]. Antimicrob Agents Chemother, 2004, 48(9):3498-3507.

共引文献30

同被引文献8

引证文献1

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部